Opportunity Information: Apply for RFA ES 13 013

  • The National Institutes of Health in the environment health sector is offering a public funding opportunity titled "Validation and Demonstration of Devices for Environmental Exposure Assessment (R21/R33)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.113 Environmental Health.
  • This funding opportunity was created on Nov 12, 2013 and posted on Nov 12, 2013.
  • Applicants must submit their applications by Feb 4, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) Small businesses Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) State governments City or township governments Public housing authorities/Indian housing authorities Public and State controlled institutions of higher education For profit organizations other than small businesses Independent school districts Private institutions of higher education County governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments.
  • Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Apply for RFA ES 13 013

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The NIH funding opportunity "Validation and Demonstration of Devices for Environmental Exposure Assessment (R21/R33)" (RFA-ES-13-013; CFDA 93.113 Environmental Health) was designed to move promising prototype tools for measuring personal environmental exposures out of the lab and into real-world field use. The central idea is that better exposure measurement is often the limiting factor in environmental health research, especially in epidemiologic studies where exposure misclassification can weaken or obscure links between environmental factors and health outcomes. To address that gap, the FOA supports a structured, phased process that helps investigators prove that a new or improved device is not only technically sound, but also reliable, usable, and scientifically valuable when deployed with people in realistic conditions.

A defining feature of the announcement is its emphasis on partnership. Projects are expected to involve close collaboration between the people building or refining the device (tool developers, engineers, exposure scientists, or related teams) and the environmental epidemiologists who will ultimately use the device to answer health questions. This partnership requirement reflects the practical reality that devices can look great under controlled test conditions yet fail in field studies because of participant burden, inconsistent performance across settings, data handling problems, or lack of integration with epidemiologic workflows. By requiring joint work between developers and end users, the FOA aims to produce tools that are ready for broader adoption and that generate data epidemiologists can actually use.

The award mechanism is phased: an initial R21 phase followed by an R33 phase. In the R21 stage, the project focuses on iterative refinement of a prototype device through evaluation in a pilot-scale study. This phase is essentially about proving the device can perform in the real world. Key expectations include demonstrating data quality (that the measurements are credible and fit for exposure assessment), tool reliability (that it works consistently and robustly), and usability (that it can be deployed with study participants and field staff without creating unmanageable burden). The language about "iterative refinement" matters: the intent is not simply to test a static prototype once, but to use pilot findings to improve hardware, software, protocols, calibration approaches, participant instructions, and data pipelines so the tool becomes field-ready.

The second phase, R33, is geared toward demonstrating value at a larger scale in an epidemiological study. Here the device is applied in a broader study context to show it contributes something meaningful scientifically, not just technically. In practical terms, this means showing that the tool improves exposure assessment compared with conventional methods (for example, by increasing temporal resolution, capturing personal rather than ambient exposures, reducing recall bias, improving specificity for a pollutant or exposure source, or better characterizing variability across people and places). It also means showing that the improved exposure information strengthens the ability to estimate relationships between exposures and health outcomes, which is the ultimate reason epidemiology needs better measurement tools. The R33 phase is therefore positioned as the "demonstration" stage: it is meant to provide convincing evidence that the tool changes what researchers can learn, not merely that it can collect data.

Administratively, this opportunity is a discretionary NIH grant with no cost sharing or matching requirement. It was posted on November 12, 2013, with an original and current closing date of February 4, 2014, and it was archived on March 7, 2014. While the dates indicate it is not currently active, the structure and intent remain a useful model for how NIH supports translation of exposure assessment technology into epidemiologic practice.

Eligibility under this FOA was broad and inclusive across many organization types. Eligible applicants included nonprofits (both 501(c)(3) and other nonprofit categories), for-profit organizations (including small businesses), public and private institutions of higher education, and a wide range of government entities (state, county, city or township, special districts, independent school districts, and public housing authorities/Indian housing authorities). Tribal governments and tribal organizations were also eligible, along with a number of mission-relevant institution types such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian-serving institutions, and Asian American and Native American Pacific Islander-serving institutions. Importantly, foreign organizations and foreign institutions were allowed to apply, and foreign components of U.S. organizations were permitted as defined in NIH policy, which signals NIH interest in tools that can be validated across diverse environments and populations.

In short, this FOA funded a two-step pathway for exposure assessment device translation: first, prove and improve the tool in a real-world pilot while demonstrating quality, reliability, and usability (R21), then show at larger scale that the tool measurably improves exposure assessment and strengthens exposure-health analyses in epidemiologic research (R33). The program is essentially about bridging the common gap between prototype development and meaningful public health impact by insisting on field validation, end-user collaboration, and evidence that the tool actually advances environmental health science.

Frequently Asked Questions (FAQs)

What is the name of this NIH funding opportunity?

The funding opportunity is titled "Validation and Demonstration of Devices for Environmental Exposure Assessment (R21/R33)."

What is the FOA number and CFDA program associated with it?

The FOA number is RFA-ES-13-013. The CFDA listing referenced is 93.113 Environmental Health.

What is the main purpose of this FOA?

The FOA was designed to move promising prototype tools for measuring personal environmental exposures out of the laboratory and into real-world field use through a structured, phased process.

Why is NIH emphasizing new or improved exposure measurement devices in this FOA?

The FOA is based on the idea that exposure measurement is often the limiting factor in environmental health research. In epidemiologic studies, exposure misclassification can weaken or obscure links between environmental factors and health outcomes, so better measurement tools can improve scientific conclusions.

What types of tools or devices is this opportunity trying to advance?

It supports new or improved devices and tools intended for measuring personal environmental exposures, with the expectation that they can be validated and demonstrated in real-world, field-based conditions.

What does "move prototypes out of the lab and into real-world field use" mean in this context?

It means the device should be tested and refined under realistic conditions with people, field staff, and real study workflows, not only under controlled laboratory conditions.

What is the overall structure of the award mechanism?

This is a phased award mechanism with an initial R21 phase followed by an R33 phase.

What is the focus of the R21 phase?

The R21 phase focuses on iterative refinement of a prototype device through evaluation in a pilot-scale study, with the intent of proving the device can perform in the real world.

What does "iterative refinement" mean for an R21 project under this FOA?

It means the intent is not to test a static prototype once. Instead, investigators are expected to use pilot findings to improve the device and its supporting methods, such as hardware, software, protocols, calibration approaches, participant instructions, and data pipelines.

What kinds of performance expectations are emphasized for the R21 phase?

The R21 phase emphasizes demonstrating (1) data quality (credible measurements fit for exposure assessment), (2) tool reliability (consistent and robust performance), and (3) usability (deployable with study participants and field staff without unmanageable burden).

What is the focus of the R33 phase?

The R33 phase is geared toward demonstrating the value of the device at a larger scale in an epidemiological study, showing that the tool contributes something meaningful scientifically, not just technically.

What does "demonstration" mean in the R33 phase?

In the R33 phase, "demonstration" means providing convincing evidence that using the tool changes what researchers can learn by improving exposure assessment and strengthening the ability to estimate relationships between exposures and health outcomes.

How is success in the R33 phase described in the FOA summary provided?

Success is described as showing that the device improves exposure assessment compared with conventional methods and that the improved exposure information strengthens exposure-health analyses in epidemiologic research.

What are examples of how a tool might improve exposure assessment compared with conventional methods?

Examples noted include increasing temporal resolution, capturing personal rather than ambient exposures, reducing recall bias, improving specificity for a pollutant or exposure source, and better characterizing variability across people and places.

Why does this FOA place such a strong emphasis on collaboration?

The FOA emphasizes partnership because devices can perform well in controlled settings but fail in field studies due to participant burden, inconsistent performance across settings, data handling issues, or poor integration with epidemiologic workflows.

Who is expected to collaborate on projects supported by this FOA?

Projects are expected to involve close collaboration between device/tool developers (such as engineers, exposure scientists, or related teams) and environmental epidemiologists who will ultimately use the device in studies.

What practical problems is the required developer-and-end-user partnership meant to prevent?

It is meant to reduce the risk that a device will be impractical in the field due to participant burden, inconsistent field performance, data handling problems, or lack of fit with epidemiologic workflows.

Does this FOA require cost sharing or matching funds?

No. The opportunity was described as a discretionary NIH grant with no cost sharing or matching requirement.

When was this funding opportunity posted and when did it close?

It was posted on November 12, 2013, and had an original and current closing date of February 4, 2014.

Is this funding opportunity currently active?

No. It was archived on March 7, 2014, and the posted dates indicate it is not currently active.

What kinds of organizations were eligible to apply?

Eligibility was broad and included nonprofits (501(c)(3) and other nonprofit categories), for-profit organizations (including small businesses), public and private institutions of higher education, and a range of government entities.

Which government entities were listed as eligible?

Eligible government entities included state, county, city or township governments; special district governments; independent school districts; and public housing authorities/Indian housing authorities.

Were tribal governments and tribal organizations eligible?

Yes. Tribal governments and tribal organizations were listed as eligible applicants.

Were specific mission-relevant institution types included in eligibility?

Yes. The eligibility description included Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian-serving institutions, and Asian American and Native American Pacific Islander-serving institutions.

Were foreign organizations allowed to apply?

Yes. Foreign organizations and foreign institutions were allowed to apply.

Were foreign components of U.S. organizations allowed?

Yes. Foreign components of U.S. organizations were permitted, as defined in NIH policy.

What does allowing foreign applicants and foreign components signal about the FOA's intent?

It signals interest in tools that can be validated across diverse environments and populations.

What is the core pathway this FOA aimed to fund?

The FOA funded a two-step pathway: (1) prove and improve the tool in a real-world pilot while demonstrating quality, reliability, and usability (R21), and (2) demonstrate at larger scale that the tool improves exposure assessment and strengthens exposure-health analyses in epidemiologic research (R33).

What larger problem in environmental health research was this FOA trying to address?

It aimed to bridge the gap between prototype development and meaningful public health impact by insisting on field validation, end-user collaboration, and evidence that the tool advances environmental health science.

Browse more business programs for Environmental Groups

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Environment Health

Next opportunity: FY14 Nancy Foster Scholarship Program

Previous opportunity: ROSES 2013 Land Cover / Land Use Change

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA ES 13 013

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (RFA ES 13 013) also looked into and applied for these:

Funding Opportunity
Outstanding New Environmental Scientist (ONES) Award (R01) Apply for RFA ES 13 014

Funding Number: RFA ES 13 014
Agency: National Institutes of Health
Category: Environment Health
Funding Amount: $250,000
Environmental Health Sciences Core Centers (EHS CC) (P30) Apply for RFA ES 13 012

Funding Number: RFA ES 13 012
Agency: National Institutes of Health
Category: Environment Health
Funding Amount: $1,300,000
NIH Revision Awards for Creating Virtual Consortium for Translational/Transdisciplinary Environmental Research (ViCTER)(R01) Apply for PAR 14 050

Funding Number: PAR 14 050
Agency: National Institutes of Health
Category: Environment Health
Funding Amount: $250,000
Developing Mercury Inventories for Artisanal and Small scale Gold Mining Sectors in Southeast Asia Apply for OES OMM 14 001

Funding Number: OES OMM 14 001
Agency: Ocean and International Environmental Scientific
Category: Environment Health
Funding Amount: $200,000
Novel Technologies for Rapid and Sensitive Biomonitoring in Humans (R43/R44) Apply for RFA ES 14 005

Funding Number: RFA ES 14 005
Agency: National Institutes of Health
Category: Environment Health
Funding Amount: Case Dependent
SBIR E learning for HAZMAT and Emergency Response (R43/R44) Apply for RFA ES 14 003

Funding Number: RFA ES 14 003
Agency: National Institutes of Health
Category: Environment Health
Funding Amount: $100,000
Undergraduate Research Education Program (UP) to Enhance Diversity in the Environmental Health Sciences (R25) Apply for RFA ES 14 004

Funding Number: RFA ES 14 004
Agency: National Institutes of Health
Category: Environment Health
Funding Amount: $100,000
Innovative Approaches for the Identification of Mitochondria Cell Signaling Networks in Response to Environmental Stress Apply for RFA ES 14 006

Funding Number: RFA ES 14 006
Agency: National Institutes of Health
Category: Environment Health
Funding Amount: Case Dependent
Hazmat Training at DOE Nuclear Weapons Complex (UH4) Apply for RFA ES 14 009

Funding Number: RFA ES 14 009
Agency: National Institutes of Health
Category: Environment Health
Funding Amount: $700,000
Hazardous Materials Worker Health and Safety Training (U45) Apply for RFA ES 14 008

Funding Number: RFA ES 14 008
Agency: National Institutes of Health
Category: Environment Health
Funding Amount: $700,000
Childrens Environmental Health and Disease Prevention Research Centers (P50) Apply for RFA ES 14 002

Funding Number: RFA ES 14 002
Agency: National Institutes of Health
Category: Environment Health
Funding Amount: $1,500,000
Outstanding New Environmental Scientist (ONES) Award (R01) Apply for RFA ES 15 003

Funding Number: RFA ES 15 003
Agency: National Institutes of Health
Category: Environment Health
Funding Amount: $475,000
Novel Assays for Screening the Effects of Chemical Toxicants on Cell Differentiation (R41) Apply for RFA ES 15 005

Funding Number: RFA ES 15 005
Agency: National Institutes of Health
Category: Environment Health
Funding Amount: $225,000
Novel Assays for Screening the Effects of Chemical Toxicants on Cell Differentiation (R43/R44) Apply for RFA ES 15 006

Funding Number: RFA ES 15 006
Agency: National Institutes of Health
Category: Environment Health
Funding Amount: $225,000
Environmental Health Sciences Core Centers (EHS CC) (P30) Apply for RFA ES 15 007

Funding Number: RFA ES 15 007
Agency: National Institutes of Health
Category: Environment Health
Funding Amount: Case Dependent
Collaborative Activities to promote High Dimensional Molecular Analyses in NIEHS supported Childrens Environmental Health Studies (Admin Supp) Apply for PA 15 123

Funding Number: PA 15 123
Agency: National Institutes of Health
Category: Environment Health
Funding Amount: $300,000
Childrens Health Exposure Analysis Resource (CHEAR) National Exposure Assessment Laboratory Network (U2C) Apply for RFA ES 15 009

Funding Number: RFA ES 15 009
Agency: National Institutes of Health
Category: Environment Health
Funding Amount: $8,000,000
Childrens Health Exposure Analysis Resource (CHEAR) Data Repository, Analysis and Science Center (U2C) Apply for RFA ES 15 010

Funding Number: RFA ES 15 010
Agency: National Institutes of Health
Category: Environment Health
Funding Amount: $6,000,000
Childrens Health Exposure Analysis Resource (CHEAR) Coordinating Center (U24) Apply for RFA ES 15 011

Funding Number: RFA ES 15 011
Agency: National Institutes of Health
Category: Environment Health
Funding Amount: $3,300,000
Annual Program Statement Policy, Advocacy, and Communication Enhanced for Population and Reproductive Health (PACE) Apply for SOL OAA 15 000054

Funding Number: SOL OAA 15 000054
Agency: Agency for International Development
Category: Environment Health
Funding Amount: $55,000,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA ES 13 013", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.